Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesImproved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert
Arthritis Care and Research , 11/03/09
Ledwich LJ et al. – The use of a BPA significantly increased influenza and pneumococcal vaccination and documentation rates in rheumatology patients taking immunosuppressants. A nurse-driven process offered higher efficacy. An EHR programmed to alert providers is an effective tool for improving quality of care for patients receiving immunosuppressants.
Methods- Vaccination BPA developed based on immunosuppressant treatment, age, and prior vaccinations
- Site 1, a hospital-based academic practice, physicians ordered vaccinations
- Site 2, a community-based practice, physicians signed orders placed by nurses
- Demographics, vaccination rates, and documentation were obtained
- Chi-square and Fisher's exact test analysis compared vaccination and documentation rates for October 1 through December 31, 2006 (preBPA), and October 1 through December 31, 2007
- Breslow-Day statistics tested odds ratio of improvement across years between sites
- PostBPA influenza vaccination rates significantly increased
- PostBPA pneumococcal vaccination rates likewise significantly increased
- PostBPA documentation rates for influenza and pneumococcal vaccinations also increased significantly
- Site 2 (nurse-driven) had significantly higher preBPA vaccination rates for influenza than pneumococcal
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Sponsor
Article Search
Sponsor